Target
Galectin-1
Ligand
BDBM50243731
Substrate
n/a
Meas. Tech.
ChEMBL_2250674 (CHEMBL5164884)
Kd
4100000±n/a nM
Citation
 Bum-Erdene, KCollins, PMHugo, MWTarighat, SSFei, FKishor, CLeffler, HNilsson, UJGroffen, JGrice, IDHeisterkamp, NBlanchard, H Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia. J Med Chem 65:5975-5989 (2022) [PubMed] 
Target
Name:
Galectin-1
Synonyms:
14 kDa lectin | Galaptin | HPL | LEG1_HUMAN | LGALS1 | Lactose-binding lectin 1 | Lectin galactoside-binding soluble 1 | Putative MAPK-activating protein PM12
Type:
beta galactoside-binding protein
Mol. Mass.:
14713.53
Organism:
Homo sapiens (Human)
Description:
P09382
Residue:
135
Sequence:
MACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD
  
Inhibitor
Name:
BDBM50243731
Synonyms:
(2R,3S,4S,5S,6R)-3-acetoxy-5-hydroxy-6-(hydroxymethyl)-2-methoxy-tetrahydro-2H-pyran-4-yl 4-methylbenzoate | CHEMBL471376
Type:
Small organic molecule
Emp. Form.:
C17H22O8
Mol. Mass.:
354.3518
SMILES:
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1OC(C)=O |r|
Structure:
Search PDB for entries with ligand similarity: